Abstract: Total joint (knee and hip) arthroplasty involves bone reaming and the use of methyl methacrylate cement. During these procedures, venous embolization of bone marrow, fat, and cement may produce physiological sequelae including hypoxia, hypotension, pulmonary hypertension, and acute respiratory distress syndrome. We have observed these physiological findings during total shoulder arthroplasty (TSA); however, the occurrence of venous embolization has not been demonstrated in this population. The purpose of this study was to determine the incidence, magnitude, and timing of venous embolization occurring in patients undergoing TSA utilizing intraoperative echocardiography. Methods: Twenty-six patients undergoing primary TSA, presenting for cemented or noncemented TSA were prospectively studied. All patients received an intraarterial catheter and either an interscalene block with sedation or general endotracheal anesthesia. Transthoracic or transesophageal echocardiography was used for cardiac imaging. The heart was observed for emboli during five intraoperative epochs: baseline, glenoid prep, humeral reaming, humeral prosthesis insertion, and shoulder reduction. Hemodynamic data was similarly obtained during these epochs. Intraoperative images were graded by the investigators and scored using the modified Mayo Clinic System for Echogenic Emboli. All data were expressed as mean±SD; p≤0.05 was considered statistically significant. Results: Mean age 67±11 years; BMI 27±4. Six patients were female. Six patients were excluded due to inadequate visualization. Final n=20 patients with acceptable echocardiographic studies, 13 cemented, and seven noncemented TSA. During humeral insertion, 12 out of 13 cemented TSA had evidence of echogenic emboli vs. two out of seven noncemented TSA. Grade 2 or 3 echogenic emboli were visualized in eight out of 13 cemented TSA vs. zero out of seven noncemented TSA during humeral insertion. Three out of 12 cemented TSA had >20% decrease in systolic blood pressure during humeral insertion vs. zero out of seven noncemented TSA. The cemented TSA group continued to exhibit echogenic emboli in five out of 13 patients, during shoulder reduction. Discussion: Patients undergoing cemented TSA exhibit a high incidence of venous embolization during humeral insertion and shoulder reduction, compared to noncemented TSA. This parallels the experience in cemented total hip arthroplasties. Patients with severe cardiopulmonary disease may benefit from specific anesthetic management and/or an alternate surgical procedure (noncemented TSA). Background: Until recently, warfarin dosing algorithms have not accounted for genetic mutations that alter the expression/ function of enzymes involved in vitamin K metabolism (Vitamin K epoxide reductase-VKOR) and warfarin metabolism (CYP2C9). Our first aim for this study was to determine if patients who receive warfarin after total joint arthroplasty (TJA) and develop a supra-therapeutic or infra-therapeutic INR, possessed variant alleles of the VKORC1 and CYP2C9 enzymes. Our second aim was to demonstrate in these patients how preoperative knowledge of VKORC1 and CYP2C9 genotypes could optimize warfarin dose to reduce excessive bleeding in hyper-responders and thromboembolism in hyporesponders. Methods: Twelve patients who developed a supra-therapeutic INR after TJA (INR≥2.20 on postoperative day [POD] no. 3), 11 patients with an infra-therapeutic INR (INR≤1.24 on POD#3), and 12 control patients with a normal response were studied. Age, gender, ethnicity and BMI of patients in the three groups were similar, and none of these patients had any known factors that may affect the warfarin response. Results: The mutant VKORC1 A allele frequency which promotes warfarin hyper-responsiveness was 18 out of 24 (75%) in the hyper-responder group vs. four out of 22 (18%) in the hypo-responder group (p=0.0001), 18 out of 24 (75%) in hyper-responders vs. 11 out of 24 (46%) in controls (p=0.039), and four out of 22 (18%) in hypo-responders vs. 11 out of 24 (46%) in controls (p=0.046). The distribution of mutations in CYP2C9 was similar in the three groups. When the
Abstract: Total joint (knee and hip) arthroplasty involves bone reaming and the use of methyl methacrylate cement. During these procedures, venous embolization of bone marrow, fat, and cement may produce physiological sequelae including hypoxia, hypotension, pulmonary hypertension, and acute respiratory distress syndrome. We have observed these physiological findings during total shoulder arthroplasty (TSA); however, the occurrence of venous embolization has not been demonstrated in this population. The purpose of this study was to determine the incidence, magnitude, and timing of venous embolization occurring in patients undergoing TSA utilizing intraoperative echocardiography. Methods: Twenty-six patients undergoing primary TSA, presenting for cemented or noncemented TSA were prospectively studied. All patients received an intraarterial catheter and either an interscalene block with sedation or general endotracheal anesthesia. Transthoracic or transesophageal echocardiography was used for cardiac imaging. The heart was observed for emboli during five intraoperative epochs: baseline, glenoid prep, humeral reaming, humeral prosthesis insertion, and shoulder reduction. Hemodynamic data was similarly obtained during these epochs. Intraoperative images were graded by the investigators and scored using the modified Mayo Clinic System for Echogenic Emboli. All data were expressed as mean±SD; p≤0.05 was considered statistically significant. Results: Mean age 67±11 years; BMI 27±4. Six patients were female. Six patients were excluded due to inadequate visualization. Final n=20 patients with acceptable echocardiographic studies, 13 cemented, and seven noncemented TSA. During humeral insertion, 12 out of 13 cemented TSA had evidence of echogenic emboli vs. two out of seven noncemented TSA. Grade 2 or 3 echogenic emboli were visualized in eight out of 13 cemented TSA vs. zero out of seven noncemented TSA during humeral insertion. Three out of 12 cemented TSA had >20% decrease in systolic blood pressure during humeral insertion vs. zero out of seven noncemented TSA. The cemented TSA group continued to exhibit echogenic emboli in five out of 13 patients, during shoulder reduction. Discussion: Patients undergoing cemented TSA exhibit a high incidence of venous embolization during humeral insertion and shoulder reduction, compared to noncemented TSA. This parallels the experience in cemented total hip arthroplasties. Patients with severe cardiopulmonary disease may benefit from specific anesthetic management and/or an alternate surgical procedure (noncemented TSA). Background: Until recently, warfarin dosing algorithms have not accounted for genetic mutations that alter the expression/ function of enzymes involved in vitamin K metabolism (Vitamin K epoxide reductase-VKOR) and warfarin metabolism (CYP2C9). Our first aim for this study was to determine if patients who receive warfarin after total joint arthroplasty (TJA) and develop a supra-therapeutic or infra-therapeutic INR, possessed variant alleles of the VKORC1 and CYP2C9 enzymes. Our second aim was to demonstrate in these patients how preoperative knowledge of VKORC1 and CYP2C9 genotypes could optimize warfarin dose to reduce excessive bleeding in hyper-responders and thromboembolism in hyporesponders. Methods: Twelve patients who developed a supra-therapeutic INR after TJA (INR≥2.20 on postoperative day [POD] no. 3), 11 patients with an infra-therapeutic INR (INR≤1.24 on POD#3), and 12 control patients with a normal response were studied. Age, gender, ethnicity and BMI of patients in the three groups were similar, and none of these patients had any known factors that may affect the warfarin response. Results: The mutant VKORC1 A allele frequency which promotes warfarin hyper-responsiveness was 18 out of 24 (75%) in the hyper-responder group vs. four out of 22 (18%) in the hypo-responder group (p=0.0001), 18 out of 24 (75%) in hyper-responders vs. 11 out of 24 (46%) in controls (p=0.039), and four out of 22 (18%) in hypo-responders vs. 11 out of 24 (46%) in controls (p=0.046). The distribution of mutations in CYP2C9 was similar in the three groups. When the Abstract: Nationally representative trends in demographics and outcomes of patients undergoing total knee arthroplasty (TKA) are scant. Therefore, we analyzed information collected for the National Hospital Discharge Survey (NHDS) from 1990 to 2004, to elucidate trends in the demographics, comorbidities, hospital stay, in-hospital complications, and mortality of patients undergoing primary TKAs in the United States. We hypothesized that substantial changes have occurred in all of these variables over the last 15 years. Materials and methods: Data on 3,830,420 hospital discharges following primary TKA collected between 1990 and 2004 in the NHDS were analyzed in three 5-year periods (1990-1994, 1995-1999, 2000-2004) . Temporal changes in demographics, comorbidities, number of procedures, in-hospital complications, mortality, and hospital stay were analyzed. Results: We observed an increase of 125% in the number of TKAs performed nationwide and a decrease of the mean age at the time of surgery. The prevalence of TKA increased from 313 to 634 out of 100.000 habitants. The prevalence of high blood pressure, diabetes, obesity, among others, increased more than what was expected in the general population. However, the prevalence of procedure-related complications decreased. The length of stay decreased by half and remained fairly constant in the last decade (4 days). In-hospital mortality decreased from 0.50% in the first study period to 0.28 in the last period. Conclusion: We were able to identify significant changes in the majority of variables studied. Such changes reflect an increased utilization of TKA with expansion of the indications to young and sick patients. Substantial improvements in anesthesia, surgical technique, and perioperative care may explain a decrease in the overall complication rate and mortality. Further analysis and additional studies are necessary to identify causal relationships and define the impact of these changes on various aspects of the health care system. Abstract: Squeaking is reported in hard-on-hard hip bearings but not usually in polyethylene bearings. Our hypothesis is that a failure of fluid film lubrication results in an increase in friction. The squeaking results from friction-induced vibrations-a special case of forced vibration-where the frequency is determined by the natural frequency of the component parts. In vivo acoustic analysis: Sound recordings were collected from 38 patients with squeaking hips and analyzed by Fourier transformation to determine the frequencies of the emitted sound. We detected fundamental frequencies between 400 Hz and 7.5 kHz. All recordings demonstrated nonlinear frequency distribution which is typical of frictioninduced vibrations. In vitro acoustic analysis: The natural frequency of hip replacement components was determined by a simple acoustic emission analysis and by a finite element modal analysis. The natural frequencies of the ceramic heads, the ceramic liners, and the correctly assembled modular ceramic/ titanium acetabular components are above the audible range (over 18 kHz range). The fundamental frequency of the unassembled titanium shells is between 3.5 and 10 kHz, and the titanium femoral components have multiple natural frequencies between 2 and 18 kHz. We conclude that sound emissions from squeaking hips result from resonance of one or other or both of the metal parts. Furthermore, dynamic uncoupling of the ceramic insert from the titanium shell should be investigated further. Abstract: This project further investigates the known shortterm chondrotoxic effects of intra-articular bupivacaine in the glenohumeral (GH) joint in an established rabbit model by providing a longer follow-up of 3 months and additional analyses. Thirty-six rabbits were randomized to receive either normal saline (NS; group 1), 0.25% bupivacaine (B; group 2), or 0.25% bupivacaine and epinephrine (B + E; group 3) via a unilaterally placed (left-L) GH, intra-articular pain pump. The right (R) shoulder was a negative control. Catheters were removed at 48 h, and animals were killed at 3 months. X-rays of both shoulders were obtained. Humeral head cartilage was weighed and analyzed for levels of proteoglycan (PG) synthesis (S35 uptake), and cell viability was assessed with live/dead cell staining. The cartilage was stained with safranin O for histology. Analysis included analysis of variance, Tukey post hoc test, and Student's t tests (p<0.05). There were no XR changes, and bacteria cultures obtained at killing were negative. There was no difference between the wet weight of the L and R shoulders in group 1 (p=0.97); groups 2 and 3 showed an increase in the L compared to the R (p=0.03 and 0.008, respectively). DNA content and cell viability was similar in all groups. The levels of PG synthesis increased in groups 2 and 3 compared to group 1 (p<0.04). The safranin O histology analysis of the cartilage showed reduction of staining at the outermost zones as well as clone formation. Our previous study showed that cell viability at 1 week decreased for groups 2 and 3; however, at 3 months, we find no difference. This raises the possibility that the number of chondrocytes has been restored during this 3-month period via recovery of apoptotic cells and/or cloning of viable cells. The activity of cytokine-like factors in stimulating metabolic activity cannot be ruled out. Similar PG staining across all groups at 3 months suggests that the cells have replenished the PG deficiency noted at 1 week. These findings suggest that the changes at 1 week were transient, and the cells were either not necrotic or became more metabolically active in response to the insult. Abstract: The etiology of rotator cuff disease and the natural history of the blood supply to the rotator cuff have not been definitively established. To date, there has not been a live, dynamic assessment of the baseline vascularity of the asymptomatic rotator cuff. This study was designed to test the hypothesis that: (1) regional variations in blood flow to the supraspinatus exist with an age-dependent decrease in the vascular supply to the tendon, and (2) exercise will demonstrate a significant increase in this blood flow which will enhance our ability for assessment and analysis. Methods: Using a novel lipid microsphere(Perflutren) contrast-enhanced ultrasound technique, 31 patients (mean age: 41.5; 20-30: n=8; 30-40: n=8; 40-50: n=5; 50-60: n=5; 60-70: n=5) underwent scanning of a randomly selected shoulder with images obtained at baseline, after contrast administration, and after contrast administration following exercise. Exclusion criteria included a history of shoulder pathology, tobacco use, or cardiovascular disease as well as a rotator cuff tear >20%. Images were obtained using a linear transducer operating in contrast harmonic mode. Qualitative and quantitative analysis was performed by determining four regions-of-interest (bursal and articular medial, bursal and articular lateral) with ultrasound analysis software. Each region was measured with normalization of data for interpretation of mean intensity per pixel. Two 4-min acquisitions were obtained from which baseline and peak enhancement were estimated for each region. Results: A statistically significant decrease in blood flow to the tendon with age was observed in a comparative analysis of patients under and over 40 (P<0.05 for all zones before exercise and the bursal medial, articular medial, and bursal lateral zones after exercise; P=0.06 for articular lateral after exercise). A significant regional variation in blood supply to the tendon was observed as well as a significant increase in blood flow with exercise in an analysis of all patients (P<0.001). Discussion: This study is the first to demonstrate in vivo an age-dependent decrease in blood supply to the supraspinatus tendon in asymptomatic individuals with an intact rotator cuff. The age-related decrease in the vascular supply of the tendon observed in this study is consistent with reports in the literature demonstrating an increasing prevalence of rotator cuff pathology with age and may predispose to the development of rotator cuff tendonopathy and ultimately attritional tears. Abstract: The purpose of the study is to evaluate the morphine-sparing effect and improved postoperative range of motion (ROM) obtained with Celecoxib prescription in patients undergoing total knee replacement surgery. Methods: Eighty patients for TKR surgery from June 2006 to March 2007 were randomized into two groups receiving pre-and postoperative Celecoxib or not. The first dose of Celecoxib 400 mg was prescribed orally about 1 h before surgery, and Celecoxib 200 mg twice a day were administered in the first 5 days after surgery. The outcome measures included pain scores, postoperative ROM, patient-controlled analgesia (PCA) and Demerol dosage, and side effect after morphine administration. Results: The groups were comparable in age, sex, preoperative ROM, duration, and preoperative knee score in both groups. Visual Analog Score had significantly improved in the study group, either at rest (p=0.002) or with exercise (p=0.05). The active ROM was significantly increased in patients receiving Celecoxib therapy, especially in the first 72 h. The dosage of Demerol usage decreased about 21%, and the frequency of postoperative nausea and vomiting decreased about 25% in the study group. There was no significantly difference in the amount of blood loss among both groups. Abstract: There is a relatively high rate of retearing of the rotator cuff tendons following repair. Platelet-derived growth factor (PDGF) is a mitogen and chemotactic cytokine that may improve the quality of the tendon-bone interface. Our hypotheses: (1) Treatment with PDGF delivered on a collagen scaffold can improve supraspinatus tendon-bone healing. (2) The positive effects of PDGF on healing occur in a dosedependent manner. Ninety-five rats underwent unilateral detachment and repair of the supraspinatus tendon. There were five groups, with 19 rats per group: control (detachment and repair), scaffold (without PDGF), low dose PDGF (30 ug/mL), medium dose PDGF (100 ug/mL), and high dose PDGF (300 ug/mL). The animals were killed at 5 and 28 days, and analyzed using biomechanical and histologic analyses. At 28 days, there were no statistically significant differences in cross-sectional area between the five groups. Significantly lower failure loads were observed in all three dosage groups and the scaffold group when compared to the control group. With Picrosirius red staining and Safranin O staining, the highdose PDGF group exhibited the most collagen birefringence and metachromasia in the healing tendon, respectively. The scaffold group had the lowest amount of metachromasia. PDGF delivered with a scaffold does not improve biomechanical properties. The high-dose PDGF group did exhibit slightly improved collagen maturity and organization as well as proteoglycan content compared to the other four groups. Analysis of cellular proliferation and angiogenesis with PCNA and Factor VIII staining, respectively, is underway. Abstract: Osteoporosis is a major clinical problem, affecting ∼80% of elderly women and 20% of elderly men. Bisphosphonates, such as alendronate (ALN), have been shown in large clinical trials to increase bone mineral density and reduce fracture risk when given to individuals with lower bone mineral density (BMD). Previously, infrared imaging spectroscopy (FTIRI) has been used to demonstrate that iliac crest biopsies from osteoporotic patients have increased an increased collagen cross-link ratio (XLR), increased hydroxyapatite crystallinity (XST), and slightly decreased mineral content (M/M). These spectroscopic parameters are indicative of bone quality as they correlate with mechanical properties. Here we tested the hypothesis that ALN would have a significant effect on these spectroscopic parameters when imaging data from biopsies of osteoporotic women treated with ALN (10 mg/days×2 years) or placebo (vitamin D and calcium) were compared. Biopsies from a series of osteoporotic patients (T-score less than −2.5) who had been randomized to receive either ALN or placebo for 2 years were analyzed by FTIRI viewing trabecular and cortical bone separately. Data indicated that the radiographic increase in bone mineral content associated with ALN treatment was occurring to a greater extent in the cortical rather than the trabecular bone of the ileum. Other parameters were not significantly different; however, pixel distribution for each parameter in the ALN-treated group were sharper than that for similar parameters in the placebo group suggesting that the treatment resulted in making these distributions more uniform and implying that less new bone formation was occurring. This is also suggested by the slight, but not significant, decreases noted in the XLR and XST. Supported by NIH grant AR041325. Abstract: The lateral pillar classification is commonly used in the Legg-Calve-Perthes population. However, this classification relies on visual estimation and thus may be prone to variation and potential error. We hypothesize that a computeraided femoral head measurement technique is a more accurate and reliable method to classify the degree of lateral pillar involvement. Methods: A computerized software program (developed at our institution) measured the femoral head height. Utilizing a Tablet PC and Adobe, the physis was drawn as a straight line from the inferomedial point of the capital femoral epiphysis to the inferolateral point of the capital femoral epiphysis, and the remaining epiphysis was traced with the stylus. The femoral head height was calculated as perpendicular to the physis at 100 equal divisions across the physeal line. The ratio (affected/unaffected) was then calculated at 5% intervals across the physeal line (lateral to medial), and each interval was assigned a modified Lateral Pillar Classification grade as described by Herring. On two separate occasions, three investigators each completed tracings of 16 digitized AP X-rays of unilateral Perthes. The intra-and inter observer reliability was tested using weighted kappa sores. Abstract: There have been multiple studies that have provided data on the prevalence of pulmonary embolism, the probability of death from a pulmonary embolism, and risk factors for the development of pulmonary embolism following lower extremity and pelvic trauma. However, there is no information on the risk of pulmonary embolism following the surgical management of proximal humerus fractures. Methods: A review of 137 consecutive patients who underwent operative treatment for acute, isolated, proximal humerus fractures at our institution between January 1, 1998 and December 31, 2003 was performed to identify all patients who sustained a pulmonary embolism. Results: Postoperatively, seven patients sustained a pulmonary embolism that was confirmed by commuted tomography. Five patients were treated with a hemiarthroplasty, and four underwent open reduction and internal fixation. The overall incidence of pulmonary embolism in this series was 5.1%. None of the patients sustained a fatal pulmonary embolus. Conclusions: The data from this study suggest that pulmonary embolism after operative treatment of proximal humerus fractures is not low. This study raises the question about the need for prophylactic anticoagulation following routine proximal humerus repair.
